Imaging tests for the staging of colorectal cancer
Bruening W, Sullivan N, Carter Paulson E, Zafar H, Mitchell M, Treadwell J, Schoelles K
            Record ID 32014001112
            English
                                    
                Authors' objectives:
                Colorectal cancer is both the third most common type of cancer and the third most common cause of cancer-related death for both men and women. Treatment options for colorectal cancer differ depending on the clinical stage of disease at diagnosis. Our objective was to synthesize the available evidence on the comparative effectiveness of imaging tests for staging colorectal cancer.
            
                                                
                Authors' recommendations:
                ERUS is preferable to CT for preoperative rectal cancer T staging (based on evidence of low strength). Moderate-strength evidence suggests MRI is preferable to CT for detecting colorectal liver metastases. Low-strength evidence suggests that CT, MRI, and ERUS are comparable for rectal cancer N staging, where all have limited sensitivity, and for interim rectal cancer T restaging. Evidence was insufficient to allow any evidence-based conclusions about the use of PET/CT for colorectal cancer staging
            
                                    
            Details
                        
                Project Status:
                Completed
            
                                                            
                Year Published:
                2014
            
                                    
                URL for published report:
                http://www.effectivehealthcare.ahrq.gov/ehc/products/488/1962/colorectal-cancer-staging-report-140930.pdf
            
                                                            
                English language abstract:
                An English language summary is available
            
                                    
                Publication Type:
                Not Assigned
            
                                    
                Country:
                United States
            
                                                
                        MeSH Terms
            - Neoplasm Staging
- Diagnostic Imaging
Contact
                        
                Organisation Name:
                Agency for Healthcare Research and Quality
            
            
                        
                Contact Address:
                Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
            
                                    
                Contact Name:
                martin.erlichman@ahrq.hhs.gov
            
                                    
                Contact Email:
                martin.erlichman@ahrq.hhs.gov
            
                                    
                Copyright:
                Agency for Healthcare Research and Quality (AHRQ)
            
                    
                This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.